Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant declines » significant decline (Expand Search), significantly declined (Expand Search), significant nonlinear (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant declines » significant decline (Expand Search), significantly declined (Expand Search), significant nonlinear (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
-
2861
-
2862
-
2863
-
2864
-
2865
-
2866
Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.
Published 2025Subjects: -
2867
-
2868
-
2869
-
2870
-
2871
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
Published 2025Subjects: -
2872
-
2873
-
2874
-
2875
-
2876
-
2877
-
2878
Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
Published 2024“…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”
-
2879
Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
Published 2024“…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”
-
2880
Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
Published 2024“…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…”